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Sickle Cell Anemia (SCA) is a group of 
inherited red blood cell (RBC) disorders 
caused by a single mutation on the β-globin 
gene which causes the synthesis of an 
abnormal hemoglobin S (HbS) (Connes et al., 
20118). A healthy red blood cell has a round 
shape that allows it to easily move through 
small blood vessels to carry oxygen to supply 
to all parts of the body (CDC, 2017). In SCA 
individuals, the sickle cell assumes a C-shape 
called “sickle” (CDC, 2017). This sickle shape 
gets them to stuck and clog the blood flow 
when moving through the small blood vessels, 
this lead to the typical symptoms of pain and 
infection, and complication such as chest 
syndrome and stoke (CDC, 2017). 
African countries carry the highest 
incident of individuals with the SCA (Centers 
for Disease Control and Prevention (CDC), 
2017). In the United State, approximately 1 in 
12 African-Americans carry the trait for SCA, 
and 1 of every 350 African-American infants 
born have the disorder (CDC, 2017). However, 
the disease is also familiar with Hispanics, 
Indians, and individuals with Asian 
backgrounds (CDC, 2017).
➢ SCA is a genetic disorder inherited from a mother, father, or both parents that are present 
from birth. SCA is as a result of a single mutation on a hemoglobin-beta gene which causes 
the synthesis of an abnormal hemoglobin S (HbS) (Connes et al., 20118). Hemoglobin (Hb) is 
a molecule in RBC responsible for the transportation of oxygen hence during deoxygenation, 
HbS polymerizes and causes sickle cell deformity which also initiates a pathological cascade 
that results in injury to the red sickle cell, hemolysis, and vaso-occlusion of RBC (Connes et 
al., 2018). 
➢ The sickle-shaped RBC causes a blockage that slows or stops the flow of blood(Connes et al., 
2018). When this happens, oxygen cannot reach targeted tissues. Deoxygenation can cause 
attacks of sudden and severe pain called “pain crises” (Connes et al., 2018) Due to the 
deformed shape, cells can also stick to vessel walls, and HbS induces RBC membrane damage 
leading to an imbalance of calcium, potassium, and water exchange into and out of the cell 
(Waltz & Connes, 2014). Accumulation of Calcium within the cell allows for the efflux of 
potassium and water from the cell, which leads to dehydration and Vaso-occlusive crisis 
(Waltz & Connes, 2014). The vasso-occlusion causes an obstruction and reduce blood flow to 
the vital organs leading to ischemia, necrosis, and pain. Repeated episodes of deoxygenation 
and oxygenation weaken the RBC cell membranes (Smith, 2014). The average life span of a 
healthy RBC is 90 to 120 days. However, weakened RBCs are hemolyzed and removed within 
10 to 20 days resulting in increased demand for RBC production that produces the 
symptoms of feeling fatigued and lethargy (Waltz & Connes, 2014).
➢ SCA has an autosomal recessive inheritance pattern, which means an individual must inherit 
two copies of a recessive allele from both parents in order to have the condition: individuals 
that carry one dominant and one recessive allele are carriers (CDC, 2017). Sickle cell carriers 
usually live a healthy life and do not exhibit any of the signs of the disease; however, they can 
pass the trait on to their offspring (CDC, 2017).
➢ The risk for septicemia and meningitis is prevalent in about 10% of children with SCA during 
the first three years of life; bacterial infections are the most common cause of death at any 
age (Matthie & Jenerette, 2015). The swelling and inflammation of the hands and other 
infections are caused by poor blood circulation due to blocked vessels (Matthie & Jenerette, 
2015). Severe abdominal pain is caused by splenic sequestration that’s blood pooling within 
the spleen, which causes the spleen to become enlarged (splenomegaly) (Matthie & Jenerette, 
2015). Breathing complications (chest syndrome) results from lack of oxygen being 
transported from the lungs to other areas of the body and retention of carbon dioxide (Smith, 
2014). Deoxygenation and high levels of carbon dioxide also cause other complications of the 
heart, brain, and muscles as these organs rely on oxygen for homeostasis (Smith, 2014).
The most serious, acute complications of SCA 
include: 
❖ cardiovascular collapse due to acute 
sequestration crisis
❖ cerebrovascular accident 
❖ acute respiratory distress syndrome due to 
acute chest syndrome 
❖ aplastic crisis that progresses to high-
output heart failure
❖ pneumonia and infections that progress to 
septicemia
The most serious, chronic complications of SCA 
include organ failure of the heart, liver, and kidney 
and loss of vision that may lead to complete 
blindness.  
During crisis, signs and symptoms may 
include
❖ Pallor 
❖ Pain crisis
❖ Fatigue
❖ Lethargy
❖ Anemia
❖ Jaundice
❖ irritability
❖ swelling of hands, feet and joints. 
(Matthie, & Jenerette, 2015).
❑ Understanding the etiology and the pathophysiology 
underlining the SCA will enable health care providers to 
effectively manage symptoms and treat pain to improve the 
quality of life in this patients population. 
❑ Primary prevention involves genetic counseling and general 
public knowledge about the pathophysiological process of the 
disease.
❑ Early detection through embryonic and newborn screening is 
necessary to reduce morbidity.
❑ Management of SCD is mainly prevention of complications and 
aggressive treatment of hydration during a crisis as well as 
pain management. For children, prophylactic antibiotics and 
pneumococcal vaccines are encouraged as well as stroke 
prevention techniques.
❑ that bone marrow transplant is the only evidenced base cure 
for sickle cell anemia and other experimental trails such as 
gene therapy, nitric oxide, and drugs that helps to boost 
hemoglobin production and reduce viscosity such as GMI 1070 
are underway (Wun et al., 2014).
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❖ Every healthy adult hemoglobins consist of two alpha chains with 
141 amino acids in sequence complemented non-alpha chains of 
beta, gamma or delta (Bellas, 2018). The non-alpha chain instead 
composes of 146 amino acids in the sequence (Bellas, 2018).
❖ Sickling of RBC happens when a healthy alpha chain of amino 
acid of Hemoglobin is substituted with the beta chain (Bellas, 
2018). This result in the abnormal synthesis of one of the amino 
acid chains on chromosome 11(Bellas, 2018). 
❖ Every beta-globin chain has a sequenced group of amino acids 
indicating glutamine in the sixth position from the terminal end 
(Bellas, 2018). In SCA, the abnormal beta-globin chain is a result 
of a substitution of glutamine amino acid by valine indicated on 
the sixth position of the beta chain which results in abnormal 
HbS present in the person’s red blood cells (Bellas, 2018).
❖ The inheritance of a single abnormal amino acid makes an 
individual a carrier with sickle cell trait which means that the 
person inherits one copy of alpha (α) chains (HBA) and one copy 
of beta (β) chains (HbS) (Bellas, 2018). Receiving two copies of 
mutated two beta (β) chains (HbS) inheritance results in sickle 
cell disease (SCD) with severe signs and symptoms that alter the 
person’s quality of life and life span (Bellas, 2018).
Conclusion
SCA is an inherited blood disorder where 
RBC takes an abnormal C-shape which impedes 
blood flow in vessels (Onimoe & Smarzo, 2017). 
This obstruction of blood blow causes Vasso-
occlusion that result in acute illness and 
progressive multiple organ damage. Pain 
“crisis” is the hallmark symptoms of SCA 
(Onimoe & Smarzo, 2017). SCA is caused by a 
mutation in the hemoglobin beta gene situated 
on chromosome 11 (Bellas, 2018). SCA is a 
recessive genetic disorder where two copies of 
mutated genes have to be inherited from both 
parents for one to portray the symptoms 
(Bellas, 2018). Individuals who inherit a  copy 
of the mutated gene are referred to be the sickle 
cell trait carrier who may live symptoms free in 
their lifespan (Bellas, 2018).The average life 
expectancy for this population has increased as 
a result of improved management of symptoms 
and bone marrow replacement (Gardner, 
2018). Health care providers ensure to educate 
patients on the importance of following 
medication regime to reduce aggregation of 
symptoms to prevent complication (Waltz & 
Connes, 2014). Both family and patient 
education are essential to reduce prevalence 
and complication of SCA.
Knowing the pathophysiology 
of the disease, the nurse will treat 
pain with analgesics and hydration 
promptly.  The nurse educates and 
advocate for the patients and 
family about their treatment 
options The nurse ensures that 
patients stay current on their 
childhood vaccinations, 
pneumococcal vaccine, and the 
annual flu shot for prevention of 
infection and other complications 
(Onimoe & Smarzo, 2017). The 
nurse will educate patients about 
pain medication tolerance, how to 
manage stress and explore other 
pain relief techniques such as heat, 
therapy, acupuncture, and when to 
contact the healthcare provider 
(Onimoe & Smarzo, 2017). The 
nurse will provide resources for 
community support groups and 
organizations that will help 
patients with other specialty 
coping mechanisms 
Nurses play a significant role in the 
management of signs and symptoms and 
treatment of individuals with SCA. Since 
treatment is aimed at relieving of 
symptoms and prevention of 
complication educating patients on 
taking their prescribed medications such 
as antibiotics, vitamins, and other pain-
relieving medicines to prevent a crisis is 
essential (Smith, 2014). Nurses ensure 
to teach patients effective measures to 
prevent crisis such as drinking more 
fluids, staying warm, avoiding large 
crowds, avoiding smoking, and second-
hand smoking (Matthie & Jenerette, 
2015). The nurse teaches the parents to 
understand effective measures to 
control pain. For the teen and adult, the 
nurse educates patients to choose safe 
physical activities that can improve pain 
management yet reduce stress on the 
joint to avoid further complications 
(Waltz & Connes, 2014). During a crisis, 
nurses ensure to prevent infection, and 
carefully assess patients for early signs 
of complications that indicate damage to 
any organ, and promptly report critical 
labs and negative diagnostic test for 
specific treatment including possible 
surgery and blood transfusions (Matthie
& Jenerette, 2015).
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SCA is a public concern. The cost of 
hospital stay during crisis and management of 
complication of SCA was estimated at $488 
billion (CDC, 2017). With early and effective 
interventions, there could be a decrease in 
hospitalizations for cost-effectiveness and also
increase life expectancy and overall quality of 
care delivered to individuals in this population. 
Understanding the pathophysiology underlining 
SCA will enable health care providers to 
effectively manage symptoms, prevent 
complication and treat pain to improve quality 
of life in this patients population. 
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